Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics Net Income (Quarterly) : -29.89M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.89M |
| March 31, 2026 | -26.78M |
| December 31, 2025 | -20.44M |
| September 30, 2025 | -20.28M |
| June 30, 2025 | -18.07M |
| March 31, 2025 | -16.48M |
| Date | Value |
|---|---|
| December 31, 2024 | -15.85M |
| September 30, 2024 | -25.44M |
| June 30, 2024 | -8.552M |
| March 31, 2024 | -11.85M |
| December 31, 2023 | -11.88M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.100B |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Immunic, Inc. | -34.10M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 29.89M |
| EPS Diluted (Quarterly) | -0.6619 |
| Enterprise Value | 35.96M |
| Earnings Yield | -38.80% |
| Normalized Earnings Yield | -38.80 |